Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Influenza A Virus Infection in Pigs Attracts Multifunctional and Cross-Reactive T Cells to the Lung.

Talker SC, Stadler M, Koinig HC, Mair KH, Rodríguez-Gómez IM, Graage R, Zell R, Dürrwald R, Starick E, Harder T, Weissenböck H, Lamp B, Hammer SE, Ladinig A, Saalmüller A, Gerner W.

J Virol. 2016 Sep 29;90(20):9364-82. doi: 10.1128/JVI.01211-16. Print 2016 Oct 15.

2.

A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.

Di Mario G, Garulli B, Sciaraffia E, Facchini M, Donatelli I, Castrucci MR.

Virol J. 2016 Mar 31;13:56. doi: 10.1186/s12985-016-0513-7.

3.

Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.

Valkenburg SA, Josephs TM, Clemens EB, Grant EJ, Nguyen TH, Wang GC, Price DA, Miller A, Tong SY, Thomas PG, Doherty PC, Rossjohn J, Gras S, Kedzierska K.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4440-5. doi: 10.1073/pnas.1603106113. Epub 2016 Mar 31.

4.

Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.

van de Sandt CE, Kreijtz JH, Geelhoed-Mieras MM, Nieuwkoop NJ, Spronken MI, van de Vijver DA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2015 Nov 4;90(2):1009-22. doi: 10.1128/JVI.02439-15.

5.

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head.

Wiersma LC, Rimmelzwaan GF, de Vries RD.

Vaccines (Basel). 2015 Mar 26;3(2):239-62. doi: 10.3390/vaccines3020239. Review.

6.

Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.

Machkovech HM, Bedford T, Suchard MA, Bloom JD.

J Virol. 2015 Nov;89(22):11275-83. doi: 10.1128/JVI.01571-15. Epub 2015 Aug 26.

7.

Reply to van de Sandt and Rimmelzwaan: Matching epitope display with functional avidity.

Keskin DB, Reinhold BR, Zhang GL, Ivanov AR, Karger BL, Reinherz EL.

Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2418. doi: 10.1073/pnas.1503931112. Epub 2015 Apr 6. No abstract available. Erratum in: Proc Natl Acad Sci U S A. 2015 May 26;112(21):E2845.

8.

Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.

Bolton KJ, McCaw JM, Brown L, Jackson D, Kedzierska K, McVernon J.

PLoS One. 2015 Mar 26;10(3):e0120138. doi: 10.1371/journal.pone.0120138. eCollection 2015.

9.

Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity.

Keskin DB, Reinhold BB, Zhang GL, Ivanov AR, Karger BL, Reinherz EL.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2151-6. doi: 10.1073/pnas.1423482112. Epub 2015 Feb 2.

10.

Advancements in the development of subunit influenza vaccines.

Zhang N, Zheng BJ, Lu L, Zhou Y, Jiang S, Du L.

Microbes Infect. 2015 Feb;17(2):123-34. doi: 10.1016/j.micinf.2014.12.006. Epub 2014 Dec 18. Review.

11.

The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin.

Thyagarajan B, Bloom JD.

Elife. 2014 Jul 8;3. doi: 10.7554/eLife.03300.

12.

Universal immunity to influenza must outwit immune evasion.

Quiñones-Parra S, Loh L, Brown LE, Kedzierska K, Valkenburg SA.

Front Microbiol. 2014 Jun 12;5:285. doi: 10.3389/fmicb.2014.00285. eCollection 2014. Review.

13.

Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.

van de Sandt CE, Kreijtz JH, de Mutsert G, Geelhoed-Mieras MM, Hillaire ML, Vogelzang-van Trierum SE, Osterhaus AD, Fouchier RA, Rimmelzwaan GF.

J Virol. 2014 Feb;88(3):1684-93. doi: 10.1128/JVI.02843-13. Epub 2013 Nov 20.

14.

Stability-mediated epistasis constrains the evolution of an influenza protein.

Gong LI, Suchard MA, Bloom JD.

Elife. 2013 May 14;2:e00631. doi: 10.7554/eLife.00631.

15.

Evasion of influenza A viruses from innate and adaptive immune responses.

van de Sandt CE, Kreijtz JH, Rimmelzwaan GF.

Viruses. 2012 Sep;4(9):1438-76. doi: 10.3390/v4091438. Epub 2012 Sep 3. Review.

16.

Nuclear export signal and immunodominant CD8+ T cell epitope in influenza A virus matrix protein 1.

Terajima M, Ennis FA.

J Virol. 2012 Sep;86(18):10258; author reply1259-60. doi: 10.1128/JVI.00894-12. No abstract available.

17.

Steric recognition of T-cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes.

Hsu SC, Chang CP, Tsai CY, Hsieh SH, Wu-Hsieh BA, Lo YS, Yang JM.

Immunology. 2012 Jun;136(2):139-52. doi: 10.1111/j.1365-2567.2011.03542.x. Erratum in: Immunology. 2012 Aug;136(4):459.

18.

Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.

Hillaire ML, Osterhaus AD, Rimmelzwaan GF.

J Biomed Biotechnol. 2011;2011:939860. doi: 10.1155/2011/939860. Epub 2011 Oct 5. Review.

19.

Targets for the induction of protective immunity against influenza a viruses.

Bodewes R, Osterhaus AD, Rimmelzwaan GF.

Viruses. 2010 Jan;2(1):166-88. doi: 10.3390/v2010166. Epub 2010 Jan 14.

20.

Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo.

Fedichev P, Timakhov R, Pyrkov T, Getmantsev E, Vinnik A.

PLoS Curr. 2011 Aug 7;3:RRN1253. doi: 10.1371/currents.RRN1253.

Supplemental Content

Support Center